Global Market Study on Neurostimulation Devices: Deep Brain Stimulation Devices to Witness Highest Growth by 2020
Description
- Neurostimulation
Devices
Neurology
is a branch of medical science that deals with the diagnosis and
treatment of diseases of central nerves system (CNS), autonomic
nerves system (ANS), and peripheral nervous system (PNS) through
medications and neurostimulation devices. A neurostimulation device
delivers mild electronic signals to the nervous system, which develop
tingling sensations (paresthesia) in the damaged nerve and helps in
the treatment of chronic pain and neurological disorders.
The
increasing prevalence of chronic pain and rising incidences of
neurological diseases are some major drivers of the global
neurostimulation devices market. Moreover, rising awareness about
various neurological diseases, growing geriatric population, and
increasing investments in research and development of innovative
neurostimulation devices are also supporting the growth of this
market. However, availability of alternative treatment therapies for
neurological diseases and side-effects of neurostimulation therapy
are some of the major restraints for the global neurostimulation
devices market.
To
Browse a Report Detail with TOC @
http://www.researchmoz.us/global-market-study-on-neurostimulation-devices-deep-brain-stimulation-devices-to-witness-highest-growth-by-2020-report.html
In
terms of geography, North America dominates the neurostimulation
devices market owing to increasing prevalence of various neurological
diseases and various initiatives taken by private and government
organizations to raise awareness about chronic pain and neurological
disorders in the region. Furthermore, technological advancements in
neurostimulation devices are also supporting the growth of the
neurostimulation devices market in the region. In Europe, the
neurostimulation devices market is growing due to initiatives taken
by various government organizations to improve healthcare services in
the region. In addition, increasing the prevalence of chronic pain
and neurological disorders and growing aging population are also
supporting the growth of this market in the region.
Asia
Pacific represents the fastest-growing neurostimulation devices
market due to growing incidence of chronic pain due to conditions
such as osteoporosis and arthritis, in various countries such as
China and Japan.
This
report provides in-depth analysis and estimation of the
neurostimulation devices market for the period 2014 – 2020,
considering 2014 as the base year for the calculation. Moreover, data
pertaining to current market dynamics, including market drivers,
restraints, and recent developments, has been provided in the report.
The neurostimulation devices market is categorized on the basis of
various types of device, application, and geography. Based on the
type of device, the market comprises implantable stimulation devices
and external stimulation devices. The implantable stimulation device
segment is further sub-segmented into spinal cord stimulation (SCS),
deep brain stimulation (DBS), sacral nerve stimulation (SNS), vagus
nerve stimulation (VNS), cochlear implants (CI), gastric electric
stimulation (GES), and others. The external stimulation device
segment includes transcutaneous electrical nerve stimulation (TENS),
transcranial magnetic stimulation (TMS), and others. Based on the
application, the market covers pain management, depression,
Parkinson’s disease, urinary and fecal incontinence, epilepsy,
hearing loss, gastroparesis, and others. On the basis of geography,
the neurostimulation devices market report identifies and analyzes
the market size and forecast for North America, Europe, Asia-Pacific,
and Rest of the World (RoW).
Some
of the major players in the neurostimulation devices market are
Medtronic plc, St. Jude Medical, Inc., Boston Scientific Corporation,
Cyberonics, Inc., Cochlear, Ltd., NDI Medical, LLC, NeuroPace, Inc.,
MED-EL, and NeuroSigma, Inc. These key market players have been
profiled on the basis of attributes such as company overview, recent
developments, growth strategies, sustainability, and financial
overview.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Comments
Post a Comment